These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 28345188)

  • 1. Treatment of gonorrhoea in Auckland, New Zealand: marked variation in prescriber adherence to treatment guidelines.
    Forster R; Ng D; Upton A; Franklin R; Thomas M
    Intern Med J; 2017 Jun; 47(6):640-648. PubMed ID: 28345188
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors and characteristics of patients with gonorrhoea presenting to Auckland Sexual Health Service, New Zealand.
    Azariah S; Perkins N
    N Z Med J; 2007 Apr; 120(1252):U2491. PubMed ID: 17460741
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chlamydia and gonorrhoea, compliance with treatment guidelines and factors associatedwith non-compliant prescribing: findings form a cross-sectional study.
    Tisler-Sala A; Ojavee SE; Uusküla A
    Sex Transm Infect; 2018 Jun; 94(4):298-303. PubMed ID: 29066628
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial susceptibility among Neisseria gonorrhoeae in New Zealand in 2002.
    Heffernan H; Brokenshire M; Woodhouse R; MacCarthy A; Blackmore T
    N Z Med J; 2004 Apr; 117(1191):U817. PubMed ID: 15107886
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Will targeting oropharyngeal gonorrhoea delay the further emergence of drug-resistant Neisseria gonorrhoeae strains?
    Lewis DA
    Sex Transm Infect; 2015 Jun; 91(4):234-7. PubMed ID: 25911525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An evaluation of Neisseria gonorrhoeae antimicrobial susceptibility testing in the UK.
    Jain A; Cole MJ; Planche T; Ison CA
    J Clin Pathol; 2014 Nov; 67(11):1013-6. PubMed ID: 25078330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gonorrhoea in 21st century--international and Polish situation.
    Serwin AB; Koper M; Unemo M
    Przegl Epidemiol; 2014; 68(1):39-44, 127-31. PubMed ID: 25004630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. First line dual therapy for gonorrhoea to limit the spread of antimicrobial resistance.
    Mohammed H; Sile B; Furegato M; Woodhall S; Fifer H; Hughes G
    BMJ; 2017 Feb; 356():j565. PubMed ID: 28153820
    [No Abstract]   [Full Text] [Related]  

  • 9. Stemming the tide of drug-resistant Neisseria gonorrhoeae: the need for an individualized approach to treatment.
    Buono SA; Watson TD; Borenstein LA; Klausner JD; Pandori MW; Godwin HA
    J Antimicrob Chemother; 2015 Feb; 70(2):374-81. PubMed ID: 25331059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in implementing the new BASHH guidelines for the management of gonorrhoea.
    Rodgers S; Murgatroyd M; Perez K; Kingston M; Lee V
    Int J STD AIDS; 2014 Feb; 25(2):145-7. PubMed ID: 23970641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local outbreak of quinolone-resistant but ceftriaxone-susceptible gonorrhoea in a region of Denmark.
    Sørensen LØ; Dalager-Pedersen M; Højbjerg T; Nielsen H
    Dan Med J; 2013 Mar; 60(3):A4596. PubMed ID: 23484614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gonococcal antimicrobial resistance: challenges for public health control.
    Ndowa FJ; Ison CA; Cole MJ; Lusti-Narasimhan M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv3-4. PubMed ID: 24243877
    [No Abstract]   [Full Text] [Related]  

  • 13. Moving forward in tackling antimicrobial resistance: WHO actions.
    Lusti-Narasimhan M; Pessoa-Silva CL; Temmerman M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv57-9. PubMed ID: 24202206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antibiotic management of gonorrhoea in Ontario, Canada following multiple changes in guidelines: an interrupted time-series analysis.
    Dickson C; Taljaard M; Friedman DS; Metz G; Wong T; Grimshaw JM
    Sex Transm Infect; 2017 Dec; 93(8):561-565. PubMed ID: 28844044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gonococcal antimicrobial resistance: the implications for public health control.
    Ndowa FJ; Ison CA; Lusti-Narasimhan M
    Sex Transm Infect; 2013 Dec; 89 Suppl 4():iv1-2. PubMed ID: 24243872
    [No Abstract]   [Full Text] [Related]  

  • 16. Antimicrobial susceptibility and molecular epidemiology of Neisseria gonorrhoeae in Germany.
    Horn NN; Kresken M; Körber-Irrgang B; Göttig S; Wichelhaus C; Wichelhaus TA;
    Int J Med Microbiol; 2014 Jul; 304(5-6):586-91. PubMed ID: 24801146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serious threat of multidrug-resistant and untreatable gonorrhoea: the pressing need for global action to control the spread of antimicrobial resistance, and mitigate the impact on sexual and reproductive health.
    Ndowa F; Lusti-Narasimhan M; Unemo M
    Sex Transm Infect; 2012 Aug; 88(5):317-8. PubMed ID: 22798629
    [No Abstract]   [Full Text] [Related]  

  • 18. Trends in antimicrobial susceptibility for azithromycin and ceftriaxone in Neisseria gonorrhoeae isolates in Amsterdam, the Netherlands, between 2012 and 2015.
    Wind CM; Schim van der Loeff MF; van Dam AP; de Vries HJ; van der Helm JJ
    Euro Surveill; 2017 Jan; 22(1):. PubMed ID: 28079519
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to CDC Recommendations for the Treatment of Uncomplicated Gonorrhea - STD Surveillance Network, United States, 2016.
    Weston EJ; Workowski K; Torrone E; Weinstock H; Stenger MR
    MMWR Morb Mortal Wkly Rep; 2018 Apr; 67(16):473-476. PubMed ID: 29698384
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decline in Decreased Cephalosporin Susceptibility and Increase in Azithromycin Resistance in Neisseria gonorrhoeae, Canada.
    Martin I; Sawatzky P; Liu G; Allen V; Lefebvre B; Hoang L; Drews S; Horsman G; Wylie J; Haldane D; Garceau R; Ratnam S; Wong T; Archibald C; Mulvey MR
    Emerg Infect Dis; 2016 Jan; 22(1):65-7. PubMed ID: 26689114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.